Johnson & Johnson's share price dropped after it reported advanced negotiations for its largest acquisition to date. J&J is expanding further in the pharmaceutical and biotechnologu sector by acquiring Alza for about $12 billion. Alza would add about $1 billion to J&J's turnover in the pharmaceutical sector, where it ranks ...
Buying a membership today will give you:
To continue reading this article register now.